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Integrin α6β4E variant is associated with actin 
and CD9 structures and modifies the biophysical 
properties of cell–cell and cell–extracellular 
matrix interactions
ABSTRACT Integrin α6β4 is an essential, dynamic adhesion receptor for laminin 332 found 
on epithelial cells, required for formation of strong cell–extracellular matrix (ECM) adhesion 
and induced migration, and coordinated by regions of the β4C cytoplasmic domain. β4E, a 
unique splice variant of β4 expressed in normal tissue, contains a cytoplasmic domain of 231 
amino acids with a unique sequence of 114 amino acids instead of β4C’s canonical 1089 
amino acids. We determined the distribution of α6β4E within normal human glandular epi-
thelium and its regulation and effect on cellular biophysical properties. Canonical α6β4C ex-
pressed in all basal cells, as expected, while α6β4E expressed within a subset of luminal cells. 
α6β4E expression was induced by three-dimensional culture conditions, activated Src, was 
reversible, and was stabilized by bortezomib, a proteasome inhibitor. α6β4C expressed in all 
cells during induced migration, whereas α6β4E was restricted to a subset of cells with 
increased kinetics of cell–cell and cell–ECM resistance properties. Interestingly, α6β4E 
presented in “ringlike” patterns measuring ∼1.75 × 0.72 microns and containing actin and 
CD9 at cell–ECM locations. In contrast, α6β4C expressed only within hemidesmosome-like 
structures containing BP180. Integrin α6β4E is an inducible adhesion isoform in normal 
epithelial cells that can alter biophysical properties of cell–cell and cell–ECM interactions.
INTRODUCTION
The α6β4 integrin regulates formation of a hemidesmosome (HD) 
that is essential for normal homeostasis within the stratified epithe-
lium of the skin. The HD remodels and is associated with the response 
to the physical and chemical microenvironment (Zhang et al., 2011; 
Osmani et al., 2018). Loss or mutation of the α6β4 integrin or laminin 
332 in normal epithelial tissues results in blistering diseases, indicat-
ing its essential adhesion and signaling role (Pulkkinen and Uitto, 
1998). Integrin α6β4 also has a role in regulating endothelial re-
sponses in lung to mechanical stress (Chen et al., 2015).
Within the simplified structure of epithelial glands, α6β4 loss is 
synonymous with prostatic intraepithelial neoplasia (PIN), which has 
a high predictive value as a marker of adenocarcinoma (Bonkhoff 
and Remberger, 1998). The normal prostate gland is composed of 
two major cell types, basal and secretory luminal cells (Bonkhoff, 
1996). The basal cells attach to a basal lamina containing laminin 
332 via the α6β4 integrin through the HD interacting with anchoring 
filaments (laminin 332) that, in turn, interact with anchoring fibers 
(Collagen VII) (Knox et al., 1994; Davis et al., 2001a). The basal cells 
of the normal prostate gland contain the stem cell compartment 
expressing the α6 integrin (Bonkhoff, 1996; Schmelz et al., 2005), 
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similar to other stem cells that require it for maintenance of a stem 
cell niche in skin, glands, nerves, bone marrow, and developing em-
bryos (Jacques et al., 1998; Emsley and Hagg, 2003; Mueller et al., 
2006; Qian et al., 2006, 2007). In the prostate gland, transformed 
stem cells located in the basal layer lose critical adhesive elements 
and acquire luminal features (Bonkhoff and Remberger, 1998). Be-
cause the α6β4 integrin is critical for normal mechano-transduction, 
the known loss of the receptor expression in early prostate cancer 
would predict an alteration of the biophysical properties of normal 
basal cells of the prostate gland.
Although primary prostate cancer does not express the α6β4 in-
tegrin or assemble HDs (Nagle et al., 1995), it was recently reported 
that β4 integrin is expressed in a subpopulation of human prostate 
tumor progenitors (Yoshioka et al., 2013). Previous work established 
that formation of the HD requires the cytoplasmic domain of the β4 
integrin (Nievers et al., 2000) to regulate its assembly and disassem-
bly (Wilhelmsen et al., 2007).
Interestingly, an isoform of β4 integrin exists, created by mRNA 
splicing, that contains a unique cytoplasmic domain without the ca-
nonical regions required for HD function (van Leusden et al., 1997; de 
Melker and Sonnenberg, 1999) and whose function is unknown. This 
raised the possibility that the β4E variant could be present in early 
stages of the transition of the normal basal cells to progenitor cells. In 
this study, we used normal prostate basal cells (RWPE-1)—originally 
characterized by Bello et al. (1997) and characterized by us in three-
dimensional (3D) culture (Wang et al., 2017)—to determine the distri-
bution of α6β4E protein within normal human glandular epithelium, 
its regulation, and its effect on cellular biophysical properties.
RESULTS
Integrins β4E and β4C are present in human normal 
prostate basal cells and tissue
To determine the distribution of α6β4E protein within normal hu-
man glandular epithelium, we used the fact that the full-length β4C 
and the β4E isoform have identical extracellular domains while con-
taining different cytoplasmic sequences (Figure 1A). Using an anti-
body to the extracellular domain, both forms can be detected by 
Western blot analysis of the heterodimers (Figure 1B) in the normal 
basal cell line (RWPE-1) depending on culture conditions. In two-
dimensional (2D) culture, only β4C is expressed, whereas under 3D 
culture conditions, the β4C isoform is expressed with an inducible 
β4E isoform. The β4C degradation products, inducible with serum-
containing media (shown later in Figure 3C) were not observed in 
2D or 3D using serum-free media conditions. The induction of β4E 
over a 24- to 72-h period, detected by Western blot analysis, was 
verified by a similar increase in the quantity of the mRNA specific for 
β4E as detected by quantitative reverse transcriptase PCR (qRT-
PCR) (Figure 1B). We also tested for the presence of α6β4E het-
erodimers in human normal prostate tissue samples. Three lysates 
from normal prostate tissue were immunoprecipitated with an α6-
integrin antibody, and we retrieved the β4E integrin from all three 
samples (Figure 1B). Retrieval of the β4C was not possible, consis-
tent with previous reports that α6β4 in a mature HD complex with 
the extracellular matrix (ECM) is not readily extractable (Sterk et al., 
2000). To distinguish β4C protein and β4E by immunofluorescence 
microscopy, we used a combination of antibodies that detect the 
extracellular domain of β4, which would detect both forms, and the 
cytoplasmic domain–specific antibody to detect only the β4C form 
(Figure 1D), as previously reported by others (Ni et al., 2005). Using 
de-identified human prostate tissue, we detected the β4C subunit 
(Figure 1E, yellow) in the basal cells primarily polarized to the basal 
lamina. The β4E form (Figure 1E, red) was found within the luminal 
cell layer in a location between the cells, reminiscent of a previously 
reported suprabasal location for β4 integrin (Owens et al., 2003). 
The reference location of the basal cells was verified in a serial sec-
tion of the same tissue using a basal cell antibody cocktail contain-
ing high-molecular-weight cytokeratin (HMWCK) and p63 (Figure 
1F, brown).
Integrin β4E-tGFP is inducible in normal RWPE-1 basal cells 
and results in a functional heterodimer without altering 
integrin β4C expression
To study the biological characteristics of the β4E integrin in RWPE-1 
cells, we constructed a vector for doxycycline-inducible expression 
of a turbo-GFP (tGFP)-tagged integrin β4E (β4E-tGFP). The construct 
contains in part a cytomegalovirus (CMV) promoter with the addi-
tion of tGFP at the C-terminal end of β4E (Figure 2A) and, as others 
have shown, GFP tagging does not affect function (Geuijen and 
Sonnenberg, 2002; Tsuruta et al., 2003). Increasing doxycycline con-
centrations resulted in increased expression of β4E-tGFP without al-
tering the abundance of the endogenous β4C expression (Figure 
2B). Six different concentrations of doxycycline were used, and a 
dose- dependent and reversible increase of β4E expression was ob-
served by qRT-PCR without changing β4C expression (Supplemental 
Figure 1). Because we observed a suprabasal expression of β4E in 
the prostate luminal compartment (Figure 1), and previous work 
showed that suprabasal expression of β4 integrin was indicative of 
disrupted TGFβ signaling for clonal expansion of initiated tumor cells 
(Owens et al., 2003), we determined whether Src signaling was acti-
vated in response to β4E induction. Initiated cells have activated Src 
signaling as an oncogenic event (reviewed in Summy and Gallick, 
2003), and c-Src activation is associated with a mouse model of pros-
tate cancer progression (Cai et al., 2011). The increased β4E-tGFP 
expression resulted in increased activated Src, a marker of initiated 
tumor cells, as detected by Western blot analysis of the whole-cell 
lysate (Figure 2C), without affecting the expression of α6 or β1-
integrin protein abundance. The β4E-tGFP formed a heterodimer 
with endogenous α6 integrin and the α6p form (Davis et al., 2001b), 
as detected by immunoprecipitation of α6 integrin and retrieval of 
increasing amounts of tGFP and β4E integrin in response to doxycy-
cline as detected by tGFP antibody and the extracellular domain–
specific antibody (β4-NT). In addition, α6β1 integrin is barely detect-
able in the RWPE-1 basal cells, as expected (Sterk et al., 2000) (Figure 
2D). Quantitation of the blots is shown in Figure 2E.
Epithelial-specific induction of integrin β4E-tGFP expression 
and suppression by degradation
Because the results indicated that β4E was inducible under RWPE-1 
3D growth conditions and was observed in normal epithelial glands 
in a luminal-type compartment, we next examined whether β4E 
expression was influenced by tissue culture conditions suitable for 
epithelial or mesenchymal growth. RWPE-1 cells, as basal stem 
cells, respond to different media conditions by altering their pheno-
type (Litvinov et al., 2006; Rodriguez-Teja et al., 2016). Under basal 
epithelial maintenance conditions, that is, using keratinocyte serum-
free media (KSFM), the doxycycline treatment results in a dramatic 
increase of β4E-tGFP protein expression, from an unexpressed state 
to expression in 40.8–59% of the population, depending on 
the concentration of doxycycline, as detected by flow cytometry 
(Figure 3A). In contrast, under serum-containing media (fetal bovine 
serum [FBS]) conditions that promote mesenchymal phenotypes, 
inducible integrin β4E-tGFP protein is strikingly absent from most of 
the population, because expression values range from 11.8% to 
25.4% of the population. Examining the β4E-tGFP protein signal 
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FIGURE 1: Integrin β4E and integrin β4C are present within human prostate cell lines and 
patient-derived tissue, and β4E is distributed within the luminal cell compartment. (A) Schematic 
of the different functional domains of integrin β4C and integrin β4E variants. (B) Integrin β4 
heterodimers (B4C, B4E) can be detected in normal basal cells (RWPE-1) in 2D culture after 72 h 
or in 3D cultures after 24, 48, or 72 h by immunoprecipitation of α6 integrin, followed by 
Western blot protein analysis. Quantities of 
β4C or β4E mRNA specific for each isoform 
were detected by qRT-PCR using isoform-
specific primers. Data are shown as means ± 
SD, n = 3. Statistical comparison was done by 
nonparametric, two-tailed Student’s t test 
(***, p < 0.005). (C) Immunoprecipitation of 
α6 integrin (IP A6) and retrieval of α6β4E 
heterodimer from normal prostate tissue. 
(D) The strategy and location of the epitopes 
of the β4 N-terminus antibody (B4-NT) and 
β4C-terminus antibody (B4-CT) were used to 
detect different β4 variants in human 
prostate tissue. (E) Epifluorescence images 
show the basal distribution of the β4C 
isoform (yellow arrow) and the β4E isoform 
(red arrow). The color channels for the boxed 
region were separated to show the 
distribution of β4 N-terminus antibody 
(B4-NT) or the β4 C-terminus antibody 
(B4-CT). The distribution of HMWCK and p63 
detects the basal cell layer (F, brown) within a 
serial section of the same gland shown in E. 
Scale bars: 100 microns.
intensity per cell indicates that, under KSFM 
conditions, there is a statistically significant 
increase in β4E-tGFP protein as compared 
with cells in the FBS conditions with both 
concentrations of doxycycline treatment 
(Figure 3B). Under both culture conditions, 
β4E-tGFP mRNA expression is driven by the 
CMV promoter, so we examined whether 
the loss of β4E-tGFP protein expression un-
der the FBS condition could be due to in-
creased degradation of β4E-tGFP protein 
and used the selective and potent protea-
some inhibitor bortezomib (Adams and 
Kauffman, 2004). Previous work showed the 
degradation of β4 integrin occurs by protea-
somal activity in patient-derived keratino-
cytes (Micheloni et al., 2004). In the absence 
of bortezomib, under KSFM conditions, no 
loss of the endogenous β4C was observed 
(Figure 3C, compare lanes 1 and 2), while 
under FBS conditions, an increased produc-
tion of the endogenous β4C and its known 
degradation products (Giancotti et al., 
1992; Potts et al., 1994; von Bredow et al., 
1997) (Figure 3C, solid red arrowhead) were 
observed (Figure 3C, compare lanes 1 and 
3). In the presence of bortezomib, under 
KSFM conditions, both the endogenous 
β4C and the inducible level of β4E-tGFP 
(Figure 3C, open red arrowhead) were in-
creased (Figure 3C, compare lanes 2 and 6). 
In the presence of the proteasome inhibitor 
bortezomib, under FBS conditions, the en-
dogenous β4C was increased and the deg-
radation products were not observed, as 
expected (Figure 3C, compare lanes 3 
and 7). Under FBS conditions, the induced 
β4E-tGFP was decreased (Figure 3C, 
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compare lanes 2 and 4), consistent with the flow-cytometry data 
(Figure 3, A and B). Taken together, the data indicate that, under the 
influence of FBS, β4E-tGFP protein expression is decreased due to 
degradation, because it is increased in the presence of the protea-
some inhibitor bortezomib (Figure 3C, compare lanes 2 and 6).
The induction of β4E-tGFP could be suppressed by tissue culture 
conditions, so we next determined the optimal induction time after 
seeding the cultures. Using flow cytometry, we quantitated β4E-
tGFP protein expression in response to doxycycline treatment ad-
ministered either immediately or after 2,4, or 6 d of growth under 
KSFM conditions. A summary of the data shows that induction of 
β4E-tGFP signal intensity per cell (Figure 3D, Day 0) is maximal 
within 1 d of culture under KSFM conditions, and treatment of cells 
after 2–6 d (Figure 3D, Days 2–4) of growth, before doxycycline 
treatment, will dramatically hinder doxycycline’s ability to increase 
expression of β4E-tGTP. The loss of an “inducible window” of pro-
tein expression can be overcome by use of the proteasome inhibitor 
bortezomib (Figure 3D).
Integrin β4E-tGFP localizes to cell–ECM adhesion sites 
independent of paxillin or cell migration
Because the induction of β4E-tGFP was optimal during early cul-
ture conditions in KSFM and no endogenous β4E was expressed 
(Figure 1), we next determined whether β4E-tGFP was found 
FIGURE 2: Dose-dependent induction of integrin β4E-tGFP expression in normal RWPE-1 basal cells results in a 
functional heterodimer without altering integrin β4C expression. Schematic (A) of the construct used to generate 
doxycycline-inducible C-terminus tGFP-tagged β4E (β4E-tGFP). (B) Whole-cell lysate (WCL) Western blot analysis of 
tGFP, integrin β4C (B4C), integrin β4E (B4E), or tubulin (α-tubulin) from cells treated with increasing concentrations of 
doxycycline for 4 d. Tubulin was used as the loading control. (C) Whole-cell lysate (WCL) Western blot analysis of tGFP, 
integrin β1 (B1), integrin α6 (A6), integrin α6p (A6p), activated Src (pSRC (Y416)), total Src (SRC), or tubulin (α-tubulin) 
from cells treated with increasing concentrations of doxycycline for 4 d. Tubulin was used as the loading control. 
(D) Immunoprecipitation of α6 integrin (IP A6) and retrieval analysis of tGFP, integrin α6 (A6) and the integrin α6p 
variant (A6p), integrin β4 (B4-NT), integrin β4C (B4-CT), and integrin β1 (B1). (E) Quantitative abundance of α6β4, 
α6β4E, or α6β1 in response to increasing concentration of doxycycline for 4 d. Data are shown as means ± SD (three 
independent experiments). Statistical significance determined by one-way analysis of variance (*, p < 0.05).
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within early cell–ECM adhesion sites containing paxillin or ex-
pressed in cells induced to migrate. Epifluorescence microscopy 
analysis of the cell–ECM surface of subconfluent cultures showed 
that the distribution of β4E-tGFP occurred independent of paxillin 
adhesion sites (Figure 4A). The induction of migration using a 
scratch assay resulted in RWPE-1 cells migrating into the scratch 
and expressing paxillin and phosphotyrosine (pY20) at focal adhe-
sion sites (Figure 4B), as expected. Closer inspection of the β4E-
tGFP signal inside the scratch (Figure 4B, inside the scratch, white 
arrowheads) revealed an ECM surface–associated signal. Approxi-
mately 95% of the cells expressed the β4C isoform when migrating 
into the scratch. Interestingly, while 50% of the cells expressed 
β4E-tGFP, only 10% entered the scratch (Figure 4C). Taken 
together, these data suggested that β4E-tGFP expression was 
associated with nonmigratory cells, and the cellular remnants 
(“footprints”) prompted us to observe cell migration using time-
lapse microscopy. A time-stamped series (Figure 4D) showed an 
approximate 12-h delay in closure of the scratch in the β4E-tGFP–
expressing population compared with the uninduced population 
(Figure 4, red lines in each panel). Supplemental Movies 1 and 2 
are provided to add more detail.
Integrin β4E-tGFP localizes at CD9-positive retraction-fiber 
regions in migrating cells
Because β4 integrin is an active migration receptor on laminin and 
can localize to retraction fibers (Geuijen and Sonnenberg, 2002) 
and CD9 can localize to retraction fibers (Yamada et al., 2013), we 
investigated the distribution of β4E and CD9 in subconfluent ran-
domly migrating cells under serum-free conditions. Epifluores-
cence images at the cell–ECM region show that β4E-tGFP localized 
FIGURE 3: Epithelium-specific regulation of integrin β4E expression and its suppression by serum-induced degradation. 
(A) Flow-cytometry analysis of the cell population (cell count) containing β4E-tGFP expression (tGFP) in KSFM or in 
media containing FBS, with or without two concentrations of doxycycline for 24 h. (B) The distribution of the β4E-tGFP 
(tGFP) intensity per cell is shown under the same conditions as A. In the box-and-whisker plot, whiskers indicate 5–95% 
percentile range, and dots indicate outliers. Statistical significance was determined by unpaired t test, (****, p < 0.0001). 
(C) Whole-cell lysate and Western blot analysis of integrin β4C, β4E, and β4E-tGFP (tGFP) expression in cells treated 
with either 1µg/ml doxycycline in the presence or absence of serum (FBS) or 50 nM bortezomib, using tubulin (α-tubulin) 
as the loading control. Note that the red filled arrowhead indicates β4C degradation and the red open arrowhead 
indicates β4E. (D) β4E-tGFP (tGFP) induction intensity per cell in the population either without (No DOX) or with 
500 ng/ml doxycycline treatment done immediately after plating (Day 0) or after 2, 4, or 6 d in KSFM, or after 8 d in 
KSFM and then treated with 50 nM bortezomib for 18 h before analysis. Samples were analyzed by flow cytometry. 
Data are shown as a box-and-whisker graph. In the box-and-whisker plot, whiskers indicate 5–95% percentile range, and 
dots indicate outliers. Statistical significance was determined by unpaired t test (****, p > 0.0001).
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at the base of CD9-decorated retraction fibers (Figure 5A) and that 
β4E-tGFP and CD9 codistributed within the retraction fibers 
(Figure 5B). Interestingly, the distribution of β4E-tGFP relative to 
CD9 on retraction-fiber regions was dynamic. In migrating cells, 
β4E-tGFP localized either at the tip of retraction-fiber regions, 
while CD9 localized at the base of retraction fiber regions (Figure 
5A, 1 and 2), or at the base of retraction fiber regions, while CD9 
localized at the tip and ECM region (Figure 5B). It is important to 
note that, under 2D conditions, there is no expression of an en-
dogenous β4E (Figure 1), and only the expressed β4E (β4E-tGFP) 
FIGURE 4: Integrin β4E-tGFP at cell–ECM adhesion sites is independent of paxillin or cell migration. (A) Epifluorescence 
images at the cell–ECM show the distribution of β4E-tGFP (green), paxillin (red), and nuclei (blue) and the black-and-
white split channel images and the colocalized pixel map. Scale bars: 10 microns. (B) Scratch-induced (white dotted 
lines) cell migration reveals the cell–ECM distribution of β4E-tGFP (green) and paxillin (red) (B, top left panel), or 
β4E-tGFP isoform (green) and phosphotyrosine (pY20, red) (B, top middle panel), or β4E-tGFP (green) and β4C (red) 
(B, top right panel). All image panels show nuclei (blue). Scale bars: 100 microns. Migrating cells (inside scratch) under 
each condition (B, bottom panels) are shown. All image panels show nuclei (blue). Scale bars: 10 microns. White 
arrowheads indicate residual β4E-tGFP (green) in ECM after scratch. (C) Quantification of the percentage of cells in B 
expressing either β4E-tGFP (total or within the scratch) or β4C (total or within the scratch). Data are shown as means ± 
SD (three independent experiments). Statistical significance determined by unpaired t test (****, p > 0.0001). (D) Time-
lapse microscopy and representative time frames (0, 12, 24, 36, and 48 h) of migrating cells, either with or without 
doxycycline (DOX, No DOX) into the scratch (red dotted line). Scale bar: 100 microns.
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was monitored. Three- dimensional superresolution microscopy 
revealed that β4E-tGFP and F-actin colocalized at the base of the 
retraction fiber, and the 3D-constructed images using the z-sec-
tions showed that β4E-tGFP radiated from the base within the re-
traction fiber (Figure 5C). Taken together, these data show that 
actin and β4E-tGFP are colocated at the base of the CD9-contain-
ing retraction fiber in migrating cells.
Integrin β4E-GFP distributes into “ringlike” patterns 
containing actin and CD9 at the cell–ECM surface
The dramatic distribution of β4E-tGFP associated with retraction fi-
bers during random migration and its cell–cell distribution under 
nonmigratory conditions prompted us to determine the distribution 
of the induced integrin in confluent cultures using superresolution 
microscopy according to the scheme shown in Figure 6A. We 
FIGURE 5: Integrin β4E-tGFP localizes at CD9-positive retraction fiber regions in migrating cells. (A) Epifluorescence 
images at cell–ECM show the distribution of integrin β4E-tGFP (green, B4E-tGFP), CD9 (red, CD9), and nuclei (blue) in 
subconfluent randomly migrating cells. Top right panels show merge (first panel), β4E-tGFP only (second panel), and 
CD9 only (third panel) at higher magnification of the box 1 region. Bottom right panels show merge (first panel), 
β4E-tGFP only (second panel), and CD9 only (third panel) at higher magnification of box 2 region. Scale bar: 10 microns. 
White arrowheads indicate colocalized regions of CD9 and β4E-tGFP. (B) Epifluorescence images at cell–ECM show (first 
panel) the distribution of integrin β4E-tGFP (green, B4E-tGFP), CD9 (red, CD9), and nuclei (blue) in a single migrating 
cell. The boxed region (B, first panel) is shown at higher magnification (B, second panel, Merge) with corresponding split 
channels of β4E-tGFP only (third panel), and CD9 only (far-right panel). Arrowheads indicate colocalized regions of CD9 
and β4E-tGFP. Scale bar: 10 microns. (C) 3D-SIM superresolution microscopic images show the distribution of integrin 
β4E-tGFP (green, B4E-tGFP), F-actin (red, Phalloidin), and nuclei (blue) in a single migrating cell. Left, maximum-intensity 
projected image. The boxed region in the left panel is shown at higher magnification (a–c) as single-plane z-section 
images to show distributions of β4E-tGFP (green, B4E-tGFP) and F-actin (red, Phalloidin). (d–f) are 3D-constructed 
images at different z-angles to show the 3D structure of the boxed region. Scale bar: 1 micron.
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analyzed a subpopulation of the RWPE-1 cells that expressed β4E-
tGFP (Figure 6B), and the localization of β4E-tGFP was different from 
that of β4C (Figure 6B). Strikingly, we found a distinctive “ringlike” 
pattern at the cell–ECM interface (Figure 6C). Because others had 
reported the interaction of β4C integrin and actin during the early 
stages of HD formation (Fontao et al., 1999) and basal cells can 
contain clusters of α6β4C as it becomes incorporated into α3β1 
clusters connected to actin filaments (Sterk et al., 2000), we tested 
whether actin was present. Both β4E-tGFP and F-actin (phalloidin) 
are colocalized in the ringlike patterns (Figure 6C) and a z-section 
scan (Figure 6C′) indicates localization of the regions at the cell–
ECM surface. The Z-sections can be seen in more detail by inspect-
ing Supplemental Movie 3. Further work showed that CD9 is also 
localized to these patterns (Figure 6D). In confluent cultures, the use 
of multicolor superresolution microscopy revealed that the β4E-
tGFP signal in the ring region is a 1.75-micron cluster located below 
the actin signal, which measures ∼1.25 microns (Figure 6E). As ex-
pected, the endogenous β4C integrin colocalized with BP180 in 
RWPE-1 cells (Figure 6F) in a pattern similar to that previously re-
ported by others in keratinocytes (Nahidiazar et al., 2015). Because 
the increased β4E-tGFP expression resulted in increased activation 
of Src (Figure 2C), we next investigated whether formation of the 
ringlike structure was dependent on Src activity. In RWPE1-1 cells 
treated with PP2, a known Src inhibitor, both β4E-tGFP and F-actin 
(phalloidin) are colocalized in the ringlike patterns (Supplemental 
Figure 2, A and B). Thus, inhibition of Src activity did not change the 
formation of the ringlike patterns or β4E-tGFP localization at the 
ringlike patterns.
Biophysical properties of cell–cell and cell–ECM are 
increased by integrin β4E-tGFP expression
The data thus far suggested that the β4E-tGFP integrin was associ-
ated with the retraction fiber in randomly migrating cells, and within 
confluent cultures and tissue, it distributed with a cell–cell location in 
luminal-type cells. The localization of the laminin-binding integrins, 
including α6 integrin, in a cell–cell distribution is common in early 
embryonic cells and early morphogenic or patterning events (re-
viewed in Bulgakova et al., 2012), providing dynamic biophysical 
properties. Because our earlier work had shown cell–cell protection 
from excessive mechanical stretch mediated by the α6β4C (Chen 
et al., 2015), we tested whether cell–cell and cell–ECM biophysical 
properties were altered with the induction of β4E-tGFP expression. 
We used electric cell–substrate impedance sensing (ECIS), because 
this would provide a sensitive and quantifiable means to test 
normalized resistance kinetics in both subconfluent and confluent 
cultures. The induction of β4E-tGFP significantly increased the kinet-
ics of both the cell–ECM and cell–cell normalized resistance mea-
surements (Figure 7, A and B). A comparison of the top and hillslope 
values indicated that the highest normalized resistance (as indicated 
by plateau) were increased, with the most dramatic effect seen in al-
tering cell–cell parameters (Figure 7B) after 30 h in the time course. 
The increase in the cell–ECM parameters that were β4E-tGFP depen-
dent were observed after 24 h in confluent cultures (Figure 7A). The 
differences in resistance kinetics (cell–ECM or cell–cell) were depen-
dent upon an adhesion-functioning α6 integrin, as detected by the 
use of a well-characterized function-blocking anti–α6-integrin anti-
body (GoH3) (Figure 7, C and D). The presence of laminin 332 ligand 
was also required, because conditions without laminin coating of the 
wells (no coating) (Figure 7, E and F) resulted in no resistance kinetics 
difference between the uninduced and doxycycline-induced condi-
tions. In cells that were measured by ECIS at 1 h after plating, there 
was no detectable difference in cells treated with doxycycline versus 
untreated cells regardless of cell numbers (6250 cells per well or 
12,500 cells per well, respectively) (Supplemental Figure 3).
DISCUSSION
Previous work reported the existence of a unique β4-integrin iso-
form produced by partial retention of intronic sequences (van 
Leusden et al., 1997). The α6β4E protein is expressed in normal 
prostate glands, distributing within the luminal cells in a cell–cell 
location. The current report is, to our knowledge, the first descrip-
tion of the reversible induction of the β4E-integrin splice variant in 
normal basal cells in response to 3D culture conditions. Induction of 
β4E was context dependent, because epithelial culture conditions 
were required and inappropriate expression of β4E protein was 
eliminated by proteasome activity. The induced expression of β4E 
increased the kinetics of both the cell–cell and cell–ECM biophysical 
properties in a mature nonmigratory population. Taken together, 
these data suggest that the splice variant has a specialized function 
in the homeostasis of the normal epithelium. Many molecular details 
of the β4E splice variant remain to be determined. We speculate 
that β6β4E integrin is an ideal candidate to provide strong cell–cell 
and cell–ECM adhesion during the process of contextual remodel-
ing without committing to HD formation. The future use of animal 
models will likely add significantly to our understanding of its role in 
normal tissue homeostasis as well as in pathological processes as-
sociated with aberrant β4-integrin function. Understanding the cyto-
plasmic or lateral protein interactions of this interesting variant will 
be important, as will knowing whether its expression can be used to 
halt α6β1-integrin–dependent cancer invasion and metastasis.
The distribution of the β4E form within the luminal cell compart-
ment (Figure 1) is reminiscent of previous reports of suprabasal ex-
pression of β4 integrin (as detected only by extracellular domain 
epitopes) as a high-risk factor for malignant progression in mouse 
skin carcinogenesis (Tennenbaum et al., 1993). The resulting dis-
rupted TGFβ signaling was permissive for clonal expansion of tu-
mor-initiated cells (Owens et al., 2003). Because initiated tumor cells 
commonly have activated Src signaling as an oncogenic event 
(reviewed in Summy and Gallick, 2003) and c-Src activation is associ-
ated with a mouse model of invasive prostate cancer progression 
(Cai et al., 2011), it is intriguing that an increased Src activation ac-
companies β4E-induced expression in normal basal cells (Figure 2). 
Given that the prostate basal compartment contains the stem cells 
for the human prostate gland (Schmelz et al., 2005) and hosts the 
premalignant changes for the development of prostate cancer 
(Bonkhoff, 1996), it will be of interest to determine the contribution 
of β4E integrin to the development of PIN and the abnormal luminal 
expansion during PIN progression (Montironi et al., 1996).
Other reports show that, in the developing and small intestine, 
α6β4 is found ubiquitously at the base of the epithelium, but its 
crypt form is immunologically distinct and appears to be function-
ally inactive (Beaulieu, 1997; Teller and Beaulieu, 2001). We note 
that, in these previous studies, the functional activity of β4C was 
defined by the canonical cytoplasmic domain, which is missing in 
the β4E variant. The β4E variant increases the biophysical proper-
ties of cell–cell and cell–ECM interactions (Figure 7), which may be 
important in normal homeostasis. Recent modeling of likely stress 
requirements in tissues such as the lung, in which α6β4 responds to 
mechanical stretching (Chen et al., 2015), predicts that airway peri-
stalsis rearranges cells and stimulates a mechano-sensitive process 
to reform cell–cell adhesions (Bokka et al., 2016). We note that both 
normal lung and duodenal (small intestine) tissues express β4E, as 
indicated by RNA analysis (van Leusden et al., 1997). It remains to 
be determined whether the β4E protein is present in these tissues. 
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FIGURE 6: Integrin β4E-tGFP distributes into ringlike patterns containing F-actin and CD9 at the cell–ECM surface. 
(A) Schematic shows the use of confluent cultures. (B) Epifluorescence images at the cell–ECM show the distribution of 
β4E-tGFP (green, B4E-tGTP), β4C (B4-CT, red), nuclei (blue), and the corresponding black-and-white split-channel 
images. Scale bar: 10 microns. (C) Epifluorescence images at the cell–ECM show the distribution of β4E-tGFP (green, 
B4E-tGTP), F-actin (Phalloidin, red), and nuclei (blue). Boxed region (C, far-left panel) at higher magnification (C, second 
panel) (scale bar: 10 microns) shows the distribution of β4E-tGFP (green, B4E-tGTP), F-actin (Phalloidin, red), and nuclei 
(blue), with the corresponding colocalization of white pixels map (C, third panel) and a merged image (C, far-right 
panel). x,z-projection (C′) shows β4E-tGFP localized at the cell–ECM plane. (D) Epifluorescence images (D, far-left panel) 
at the cell–ECM show the distribution of β4E-tGFP (green, B4E-tGTP), CD9 (CD9, red), and nuclei (blue). (D, second 
panel) shows distribution of CD9 (green), F-actin (phalloidin, red), and nuclei (blue). (E) Representative 3D-SIM 
superresolution images at different z-sections show the distribution of β4E-tGFP (green, B4E-tGTP) and F-actin 
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(Phalloidin, red) as a ringlike pattern from cell–ECM to cytoplasm. Scale bars: 1 micron. (F) Representative images show 
β4C localized at HD-like structures at cell–ECM. Left panel shows the distribution of BP180 (Green, BP180) and β4C 
(red, B4C) at cell–ECM. Middle and right panels show the corresponding colocalization white pixels map between 
BP180 and β4C. HD-like structures were defined as colocalization of BP180 and β4C. Nuclei are shown in blue. Scale 
bar: 10 microns.
FIGURE 7: The kinetics of biophysical properties of cell–ECM and cell–cell are increased by 
integrin β4E-tGFP expression in confluent cultures. Untreated cells (No DOX) and β4E-tGFP–
expressing cells cultured in doxycycline (500 ng/ml) (DOX) were plated on ECIS dishes either 
precoated with laminin 332 (A,B) or GoH3 function-blocking antibody (C,D) or uncoated (E, F) for 
5 d; this was followed by ECIS measurements using 40,000 Hz (A,C,E) or 400 Hz (B,D,F) during 
β4E-tGFP (DOX) and β4C (No DOX) induction for up to 70 h. (A, B) Inset shows the biophysical 
parameters determined using a variable slope model, known as a four parameter dose response 
curve (GraphPad Prism, v8). Equation is: Y = Bottom + (X HillSlope) × (Top-Bottom)/(X HillSlope + 
EC50 HillSlope). Data are shown as means ± SD (three independent experiments).
Considering the current study, a cell–cell location of β4E would pro-
vide a testable molecular explanation for maintaining strength of 
adhesion without the accompanying adhesion complex formation 
dictated by the canonical β4C cytoplasmic domain.
The results reported here showed that α6β4C was expressed in 
all cells during induced migration, consistent with previous reports 
(reviewed in Mercurio et al., 2001). However, the α6β4E expression 
was distinct from α6β4C and restricted to a subset of migratory cells 
with increased cell–cell and cell–ECM resistance properties. Surpris-
ingly, superresolution microscopy revealed 
a ringlike pattern of β4E-tGFP at the cell–
ECM surface in confluent cultures, contain-
ing both actin and CD9. In the plasma mem-
brane, ringlike structures called flat clathrin 
lattices (FCLs) exist on dorsal or ventral sur-
faces (Grove et al., 2014) and contain spe-
cific receptors, including the αvβ5 integrin 
(Zuidema et al., 2018). The content of the 
FCL is dynamic, because lowering actomyo-
sin contractility will increase the redistribu-
tion of integrin β5 to FCLs (Zuidema et al., 
2018). FCLs are F-actin–controlled struc-
tures that oppose migration (Leyton-Puig 
et al., 2017) or in other systems are contrac-
tility–independent structures formed as a 
result of frustrated endocytosis (Baschieri 
et al., 2018). Because the work reported 
here shows that β4E integrin is associated 
with F-actin in ringlike structures during non-
migratory conditions on the basal cell sur-
face, it will be of interest to determine 
whether β4E redistributes or resides in FCLs 
during the transition from subconfluent ran-
dom migration to confluent, nonmigratory 
cultures. Recent advances in new tools for 
the quantitative analysis of clathrin-medi-
ated endocytosis during differentiation 
would likely assist these studies (Dambour-
net et al., 2018). A limitation of the current 
work is that the model uses an induced β4E-
tGFP without the expression of an endoge-
nous β4E. Future work will likely determine 
the dynamic of the endogenously produced 
β4E in 3D culture and uncover other regula-
tory features.
Finally, we note that, in both subconfluent 
migratory and confluent nonmigratory cul-
tures, β4E-tGFP was found codistributed 
with CD9, either in retraction fibers (Figure 5) 
or in F-actin–containing ringlike structures 
(Figure 6), respectively. Previous work re-
ported that CD9 interacts with α6β4 
(Baudoux et al., 2000), is found in retraction 
fibers (Yamada et al., 2013), and is diffusely 
distributed during the assembly of (pre)-HD 
structures (Yamada et al., 2013). We specu-
late that α6β4E may associate with CD9 to serve as a temporary and 
dispensable cell–ECM adhesion site for the retraction fiber during 
migration and/or may associate with CD9 to provide increased bio-
physical properties during cell–cell closure events. In either scenario, 
we speculate that the β4E integrin containing the unique cytoplasmic 
domain may serve as an intermediary form that could provide a 
laminin adhesion function before committing to HD assembly. We 
also note that β4E residency in the specialized FCL endocytic 
platform may explain, in part, the different internalization rates of 
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laminin-binding integrins, because α6 pairs with β4, β4E, and/or β1 
as compared with α3, which pairs only with β1 (Das et al., 2017).
MATERIALS AND METHODS
Cell culture
RWPE-1 cells were obtained from the American Type Culture 
Collection (ATCC CRL-11609TM) and cultured in KSFM (GIBCO, kit 
cat. no. 17005-042), supplemented with 0.05 mg/ml bovine pitu-
itary extract (BPE) (provided with the KSFM kit), 5 ng/ml EGF (pro-
vided with the KSFM kit), 100 IU penicillin, 100 μg/ml streptomycin, 
and 0.25 μg/ml amphotericin (MP Biomedicals, cat. no. 1674049). 
RWPE-1 identity was verified by allelic signature of 15 different 
genetic markers.
Three-dimensional cell culture
RWPE-1 cells (80,000 cells in 45 μl) were placed into the top well 
chamber of a 96-well hanging-drop plate (Biomatrix 96, cat. no. 
HDP1096) according to the manufacturer’s suggestions and cul-
tured for up to 72 h. The cells were collected by centrifugation of 
the collected drops. Approximately one-third of the plate was 
required to obtain 10–20 μg of protein for analysis.
Overexpression vector constructs
For generation of inducible β4E-tGFP expression constructs, the 
coding region for β4E-tGFP gene was inserted between AgeI-
MluI sites of the pTRIPZ/shRNA lentiviral vector downstream of 
the Tet/ON promoter (Open Biosystems). Others have shown 
GFP tagging of β4 does not impair its function (Geuijen and Son-
nenberg, 2002; Tsuruta et al., 2003). Lentivirus packaging vectors 
pMD2.G (Addgene plasmid #12259) and psPAX2 (Addgene plas-
mid #12260) were gifts from Didier Trono (Addgene, www 
.addgene.org). pTRIPZ-β4E-tGFP plasmid and lentivirus packag-
ing vectors were cotransfected into HEK-293T cells using 
Lipofectamine 3000 (Thermo Fisher Scientific, cat. no. L3000008). 
Virus was harvested 24 and 48 h after transfection, filtered through 
a 0.45-μm filter, and added to the growth media of cells supple-
mented with 8 μg/ml polybrene (Sigma-Aldrich, cat. no. H9268). 
Stable cells were selected with 500 ng/ml puromycin for at least 
2 wk. Cells were then induced with doxycycline (500 ng/ml) for 5 d 
and FACS sorted for GFP-positive cells. Sorted cells were main-
tained in normal growth medium without doxycycline.
qRT-PCR
qRT-PCR was performed using TaqMan RNA-to-Ct 1-Step Kit 
(Thermo Fisher, cat. no. 4392653) and Applied Biosystem StepOne-
Plus Real-Time PCR System (Thermo Fisher, cat. no. 4376600). β4C 
and β4E specific primers and probes were obtained using TaqMan 
Gene Expression Assays. Hs01103167_g1 was used to specifically 
detect integrin β4C mRNA, and Hs01108014_g1 was used to 
specifically detect integrin β4E mRNA.
Immunofluorescence microscopy
Cells were cultured on coverslips, washed in phosphate-buffered 
saline (PBS), and then fixed in 2% paraformaldehyde for 20 min at 
room temperature. After fixation, cells were rehydrated in PBS for 
5 min, permeabilized in PBS-0.5% Triton X-100 for 5 min, blocked in 
blocking buffer (PBS, 5% normal goat serum [Sigma], 0.1% Triton 
X-100, and 2 mM NaN3) for 30 min, and then incubated with pri-
mary antibodies in blocking buffer for 1 h at room temperature. 
Cells were washed three times, 5 min for each wash, in PBS-0.1% 
Triton X-100 and then incubated with secondary antibodies and 
Hoechst 33342 (1:1000; Invitrogen) for 1 h at room temperature. 
Cells were washed three times, 5 min for each wash, in PBS-0.1% 
Triton X-100 and mounted in 0.1M n-propyl gallate, 90% (by volume) 
glycerol, and 10% PBS solution.
Immunohistochemistry
For immunofluorescence microscopy of Formalin-fixed paraffin-
embedded (FFPE) tissue samples, FFPE blocks were sectioned at 
5-μm thickness and mounted on slides. Slides were baked at 65°C 
overnight; deparaffined through three 7-min washes in xylene; 
and then passed through 100, 75, and 50% isopropanol and 
ddH2O for rehydration. Antigen retrieval was performed using 
EnVision FLEX Target Retrieval Solution, High pH (DAKO, DM828) 
buffer and heated at 97°C using a decloaking chamber for 20 min. 
Slides were washed in washing buffer (0.1 M Tris-HCl, 0.3 M NaCl, 
0.1% Tween 20, and 7.7 mM NaN3, pH 7.6, at 25°C) followed by 
blocking buffer (5% normal goat serum, 0.1 M Tris-HCl, and 
0.15 M NaCl, pH 7.6, at 25°C) for 30 min at room temperature. 
Primary antibodies were diluted in blocking buffer and incubated 
at 4°C overnight in a humidified chamber. Slides were washed 
three times in wash buffer and incubated with secondary antibody 
and Hoechst 33342 (1:1000; Invitrogen) for 30 min to 1 h at room 
temperature. Slides were washed three times in washing buffer 
and then mounted using ProLong Diamond Antifade Mountant 
(Thermo Fisher Scientific, P36970) and stored in the dark at room 
temperature overnight to cure the mountant. Slides were imaged 
or stored at −20°C for future analysis.
HMWCK and p63 staining was performed on the Ventana 
BenchMark ULTRA instrument, and antigen retrieval was 64 min 
with 16-min antibody incubation at 36°C; the detection was 
accomplished with Ventana OptiView IHC DAB Detection Kit.
Antibodies
We used antibodies and stains for immunofluorescence microscopy 
at the following working concentrations: anti-β4 N-terminus anti-
body (1:20 for FFPE tissue samples and 1:100 for fixed cell lines; 
Abcam ab110167, 439-9B), anti-β4 C-terminus antibody (1:50 for 
FFPE tissue samples and 1:100 for fixed cell lines; Thermo Fisher 
Scientific MA5-17104, 10B10D5), anti-HMWCK and p63 (Ventana 
Basal Cell Cocktail), anti-paxillin antibody (1:100; BD Transduction 
Laboratories 610052, clone 349), anti-phosphotyrosine antibody 
(1:100; BD Transduction Laboratories, clone PY20), anti-BP180 
(1:100; clone 1D1, R.B. Nagle, University of Arizona), anti-CD9 
(1:100; GeneTex GTX19715, clone ALB 6), and phalloidin (Alexa 
Fluor 647 Phalloidin; 1:40; Thermo Fisher Scientific A22287). Sec-
ondary antibodies were purchased from Jackson Immunoresearch 
and used at 1:1500.
Chemicals
Doxycycline was purchased from Sigma-Aldrich (D9871) and was 
used as indicated in each experiment. Bortezomib was purchased 
from Selleck Chemicals (cat. no. 1013) and was used at 50 ng/ml 
overnight.
Immunoblotting
Cell extracts were produced by lysing cells in cold RIPA buffer 
(50 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA, 1% vol/vol Triton 
X-100, 1% wt/vol Na deoxycholate, 0.1% SDS, pH7.4). Samples of 
equal total protein were resolved by SDS-PAGE, blotted, probed 
with primary and secondary antibodies, and scanned on an Odyssey 
imager (Li-Cor Biosciences). Care was taken to avoid saturating 
the scans. Antibodies used for immunoblots included: anti-β4 
N- terminus antibody (1:1000; Abcam EPR8558), anti–β4C-terminus 
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antibody (1:1000; Thermo Fisher Scientific MA5-17104, 10B10D5), 
anti-tGFP antibody (1:1000; ORIGENE TA183081, clone OTI2H8), 
anti-α6 antibody (1:1000; A6NT, Cress lab), anti-β1 antibody 
(1:1000; Cell Signaling Technology 9699, clone D2E5), anti-Src anti-
body (1:1000; Cell Signaling Technology 2108), anti-phospho-Src 
family (Tyr416) (1:1000; Cell Signaling Technology 2101), and anti–
α-tubulin DM1A (1:1000; Sigma-Aldrich). IRDye 800CW secondary 
antibodies (Li-Cor Biosciences) were prepared according to the 
manufacturer’s instructions and used at 1:3000 dilutions.
Flow cytometry
Cells were trypsinized, washed with PBS, and analyzed using a BD 
Accuri C6 flow cytometer (BD Biosciences).
ECIS measurements
Electrical properties of confluent or wounded epithelium were mea-
sured using electric ECIS as described previously (Wegener et al., 
2000). Cell adhesion measurements were based on changes in resis-
tance/capacitance to current flow applied at different frequencies 
(Applied Biophysics, Troy, NY). A 96-well plate (Applied Biophysics, 
96W10idf PET) was coated with laminin at 4°C overnight, and cells 
were inoculated at 6250 or 12,500 cells per well in 200 ml in tripli-
cate, and resistance/capacitance was measured at 400 and 40,000 
Hz. Biophysical parameters were determined using a variable slope 
model, known as a four parameter dose response curve (GraphPad 
Prism, v8): Y = Bottom + (X HillSlope) × (Top-Bottom)/(X HillSlope + 
EC50 HillSlope). EC50 is the concentration of agonist that gives a 
response halfway between Bottom and Top. HillSlope describes the 
steepness of the family of curves. Top and Bottom are plateaus in 
the units of the y-axis.
Structured illumination superresolution microscopy
Superresolution 3D-structured illumination imaging was performed 
on a Zeiss ELYRA S1 system equipped with an Alpha Plan-APO 
100×/1.46 oil-immersion objective (Zeiss), and 405-, 488-, 561-, and 
642-nm lasers and pco.edge camera (PCO-Tech). Image stacks with 
three rotations per plane, 18 z-steps, and a z-distance of 0.1 μm were 
acquired and computationally reconstructed to generate superreso-
lution optical serial sections to yield resolutions in x,y of 110 nm and 
in z of 300 nm. Color channels were aligned using an alignment pa-
rameter. SI reconstruction and image processing was performed with 
the Zen v. 2.3 black-imaging software package (Zeiss).
Statistical methods
The statistical significance of differences in average measurements 
was evaluated using GraphPad Prism v. 8.0. Means are taken to be 
significantly different if p < 0.05. In figures, an asterisk (*) indicates 
0.05 > p ≥ 0.01; a double asterisk (**) indicates 0.01 > p ≥ 0.001; a 
triple asterisk (***) indicates 0.001 > p ≥ 0.0001, a quadruple asterisk 
(****) indicates 0.0001 > p, and not significant (ns) indicates p ≥ 0.05 
for the indicated pairwise comparison. Error bars in all figures 
indicate SD.
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